CAR-T cell Therapy: What is it and what does it treat?

Feb 20, 2019 | Mayo Clinic Hematology Staff | @mayoclinichematologystaff | Comments (2)

Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to recognize and destroy certain cancers.

Mayo Clinic hematologist, Dr. Yi Lin, explains what chimeric antigen receptor T-cell therapy (CAR-T cell therapy) is and what types of cancers it can be used to treat. Currently CAR-T cell therapy can be used to treat two types of cancer:

  1. B-cell ALL (acute lymphocytic leukemia) for pediatric children up to 25-year-old adults
  2. Adults with B-cell non-Hodgkin lymphoma

Want to talk with others who have experience with blood cancers and disorders as well as CAR-T cell therapy? Join the discussion in the following Connect discussion groups:

Interested in more newsfeed posts like this? Go to the Hematology blog.

Help…info Ductal invasive carcinoma


Help…info Ductal invasive carcinoma

Jump to this post

Hello @6750, CAR-T therapy is currently only approved for B-cell ALL and B-cell non-Hodgkin lymphoma. I would like to share a couple of discussions with you here on Connect where other members are posting about ductal invasive carcinoma:

Each discussion has other members you can meet who will understand where you are coming from. I suggest clicking on the links above and sharing your questions and concerns with the members who may be able to both relate and answer some of your questions.

Please sign in or register to post a reply.